 |
Trisaccharides A and B |
|---|---|
| Trade Name | Biosynject |
| Orphan Indication | Prevention of ABO medical hemolytic reactions arising from ABO-incompatible bone marrow transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1988-04-15 00:00:00 |
| Sponsor | Chembiomed, Ltd.;P.O. Box 8050, T6H 4NP; |
